Is prophylactic diabetic foot surgery dangerous?

David G. Armstrong, Lawrence A. Lavery, Sharone Stern, Lawrence B. Harkless

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Any treatment rendered to the deformed, insensate foot should be undertaken with the prime intentions of reducing the potential for future limb-threatening events and allowing the patient to continue as an ambulatory, productive member of society. The purpose of this article is to compare morbidity and outcomes of elective foot surgery among diabetics and nondiabetics with isolated toe deformities. We compared the prevalence of infection, wound complication, and recurrence of ulcers in 31 diabetics and 33 nondiabetics. All of these patients received a single proximal interphalangeal joint arthroplasty with a mean follow-up of 3 years (range, 12 to 61 months). The diabetic group was divided into two subgroups: 1) insensate with deformity, but no history of ulceration, and 2) insensate with deformity and a previous history of ulceration. Diabetics with a history of ulceration were more likely to experience a postoperative infection (14.3%) than neuropathic diabetic patients with no history of ulceration (0%) and nondiabetic subjects (0%) (p = 0.04, CI = 3.1 to 8.6). There was not a significant difference in prevalence of dehiscence among diabetic and nondiabetic groups (16.1% versus 9.1%, respectively, CI = 0.4 to 8.8). The long-term outcomes after prophylactic surgery at a site of previous ulceration were uniformly good, with 96.3% of patients remaining ulcer-free a mean of 3 years postoperatively.

Original languageEnglish (US)
Pages (from-to)585-589
Number of pages5
JournalJournal of Foot and Ankle Surgery
Volume35
Issue number6
StatePublished - Nov 1996

Fingerprint

Diabetic Foot
Ulcer
Foot
Toes
Wound Infection
Arthroplasty
Extremities
Joints
Morbidity
Recurrence
Infection
Therapeutics

Keywords

  • complications
  • diabetes
  • prophylactic surgery

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Armstrong, D. G., Lavery, L. A., Stern, S., & Harkless, L. B. (1996). Is prophylactic diabetic foot surgery dangerous? Journal of Foot and Ankle Surgery, 35(6), 585-589.

Is prophylactic diabetic foot surgery dangerous? / Armstrong, David G.; Lavery, Lawrence A.; Stern, Sharone; Harkless, Lawrence B.

In: Journal of Foot and Ankle Surgery, Vol. 35, No. 6, 11.1996, p. 585-589.

Research output: Contribution to journalArticle

Armstrong, DG, Lavery, LA, Stern, S & Harkless, LB 1996, 'Is prophylactic diabetic foot surgery dangerous?', Journal of Foot and Ankle Surgery, vol. 35, no. 6, pp. 585-589.
Armstrong DG, Lavery LA, Stern S, Harkless LB. Is prophylactic diabetic foot surgery dangerous? Journal of Foot and Ankle Surgery. 1996 Nov;35(6):585-589.
Armstrong, David G. ; Lavery, Lawrence A. ; Stern, Sharone ; Harkless, Lawrence B. / Is prophylactic diabetic foot surgery dangerous?. In: Journal of Foot and Ankle Surgery. 1996 ; Vol. 35, No. 6. pp. 585-589.
@article{c82f9782fc9f4e6f827ed58e28d0713f,
title = "Is prophylactic diabetic foot surgery dangerous?",
abstract = "Any treatment rendered to the deformed, insensate foot should be undertaken with the prime intentions of reducing the potential for future limb-threatening events and allowing the patient to continue as an ambulatory, productive member of society. The purpose of this article is to compare morbidity and outcomes of elective foot surgery among diabetics and nondiabetics with isolated toe deformities. We compared the prevalence of infection, wound complication, and recurrence of ulcers in 31 diabetics and 33 nondiabetics. All of these patients received a single proximal interphalangeal joint arthroplasty with a mean follow-up of 3 years (range, 12 to 61 months). The diabetic group was divided into two subgroups: 1) insensate with deformity, but no history of ulceration, and 2) insensate with deformity and a previous history of ulceration. Diabetics with a history of ulceration were more likely to experience a postoperative infection (14.3{\%}) than neuropathic diabetic patients with no history of ulceration (0{\%}) and nondiabetic subjects (0{\%}) (p = 0.04, CI = 3.1 to 8.6). There was not a significant difference in prevalence of dehiscence among diabetic and nondiabetic groups (16.1{\%} versus 9.1{\%}, respectively, CI = 0.4 to 8.8). The long-term outcomes after prophylactic surgery at a site of previous ulceration were uniformly good, with 96.3{\%} of patients remaining ulcer-free a mean of 3 years postoperatively.",
keywords = "complications, diabetes, prophylactic surgery",
author = "Armstrong, {David G.} and Lavery, {Lawrence A.} and Sharone Stern and Harkless, {Lawrence B.}",
year = "1996",
month = "11",
language = "English (US)",
volume = "35",
pages = "585--589",
journal = "Journal of Foot and Ankle Surgery",
issn = "1067-2516",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Is prophylactic diabetic foot surgery dangerous?

AU - Armstrong, David G.

AU - Lavery, Lawrence A.

AU - Stern, Sharone

AU - Harkless, Lawrence B.

PY - 1996/11

Y1 - 1996/11

N2 - Any treatment rendered to the deformed, insensate foot should be undertaken with the prime intentions of reducing the potential for future limb-threatening events and allowing the patient to continue as an ambulatory, productive member of society. The purpose of this article is to compare morbidity and outcomes of elective foot surgery among diabetics and nondiabetics with isolated toe deformities. We compared the prevalence of infection, wound complication, and recurrence of ulcers in 31 diabetics and 33 nondiabetics. All of these patients received a single proximal interphalangeal joint arthroplasty with a mean follow-up of 3 years (range, 12 to 61 months). The diabetic group was divided into two subgroups: 1) insensate with deformity, but no history of ulceration, and 2) insensate with deformity and a previous history of ulceration. Diabetics with a history of ulceration were more likely to experience a postoperative infection (14.3%) than neuropathic diabetic patients with no history of ulceration (0%) and nondiabetic subjects (0%) (p = 0.04, CI = 3.1 to 8.6). There was not a significant difference in prevalence of dehiscence among diabetic and nondiabetic groups (16.1% versus 9.1%, respectively, CI = 0.4 to 8.8). The long-term outcomes after prophylactic surgery at a site of previous ulceration were uniformly good, with 96.3% of patients remaining ulcer-free a mean of 3 years postoperatively.

AB - Any treatment rendered to the deformed, insensate foot should be undertaken with the prime intentions of reducing the potential for future limb-threatening events and allowing the patient to continue as an ambulatory, productive member of society. The purpose of this article is to compare morbidity and outcomes of elective foot surgery among diabetics and nondiabetics with isolated toe deformities. We compared the prevalence of infection, wound complication, and recurrence of ulcers in 31 diabetics and 33 nondiabetics. All of these patients received a single proximal interphalangeal joint arthroplasty with a mean follow-up of 3 years (range, 12 to 61 months). The diabetic group was divided into two subgroups: 1) insensate with deformity, but no history of ulceration, and 2) insensate with deformity and a previous history of ulceration. Diabetics with a history of ulceration were more likely to experience a postoperative infection (14.3%) than neuropathic diabetic patients with no history of ulceration (0%) and nondiabetic subjects (0%) (p = 0.04, CI = 3.1 to 8.6). There was not a significant difference in prevalence of dehiscence among diabetic and nondiabetic groups (16.1% versus 9.1%, respectively, CI = 0.4 to 8.8). The long-term outcomes after prophylactic surgery at a site of previous ulceration were uniformly good, with 96.3% of patients remaining ulcer-free a mean of 3 years postoperatively.

KW - complications

KW - diabetes

KW - prophylactic surgery

UR - http://www.scopus.com/inward/record.url?scp=0030456616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030456616&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 585

EP - 589

JO - Journal of Foot and Ankle Surgery

JF - Journal of Foot and Ankle Surgery

SN - 1067-2516

IS - 6

ER -